Effects of Particulate Matter on Daily Mortality in 13 Japanese Cities

BACKGROUND In recent years, numerous reports demonstrating the relationship between an increase in the concentration of fine particulate matter (PM2.5) and daily mortality have been released in the United States and Europe. There have been few studies that clearly characterize the short-term effects of particulate matter on the mortality in Japan. We conducted data analysis to investigate the short-term effects of suspended particulate matter (SPM) on mortality in Japan. METHODS In this study, we used data sets from the 13 largest cities containing data on the daily mortality of residents aged 65 years or older, concentrations of air pollutants including SPM, temperature, and humidity. Risk ratios for mortality resulting from respiratory diseases, cardiovascular diseases, and all causes other than accidents, from 1990 through 1994, were summarized using a generalized additive model (GAM) and a meta-analysis of random effect model. RESULTS The risk ratios for an increase of 10 microg/m3 in SPM concentrations adjusted for SO2, NO2, CO, Ox, temperature, and humidity were 1.0077 for all causes of mortality, 1.0109 for respiratory diseases, and 1.0091 for cardiovascular diseases, and the lower limits of the 95% confidence intervals for the risk ratios were greater than one for all cases. With regards to the effects of time lag, risk ratios were higher for the SPM concentrations on the day when the mortality was recorded, and the preceding day. CONCLUSIONS These results suggest a positive relationship between SPM concentrations and daily mortality in Japan.

[1]  A. Peters,et al.  Associations between mortality and air pollution in central Europe. , 2000, Environmental health perspectives.

[2]  J Schwartz,et al.  Air pollution and daily mortality: associations with particulates and acid aerosols. , 1992, Environmental research.

[3]  Joel Schwartz,et al.  Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease , 1997, BMJ.

[4]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[5]  J Schwartz,et al.  Short-term effects of ambient sulphur dioxide and particulate matter on mortality in 12 European cities: results from time series data from the APHEA project. Air Pollution and Health: a European Approach. , 1997, BMJ.

[6]  J Schwartz,et al.  Increased mortality in Philadelphia associated with daily air pollution concentrations. , 1992, The American review of respiratory disease.

[7]  Scott L. Zeger,et al.  Air Pollution and Mortality , 2002 .

[8]  J. Schwartz,et al.  The National Morbidity, Mortality, and Air Pollution Study. Part II: Morbidity and mortality from air pollution in the United States. , 2000, Research report.

[9]  F. Dominici,et al.  Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. , 2000, The New England journal of medicine.

[10]  J Schwartz,et al.  Confounding and Effect Modification in the Short-Term Effects of Ambient Particles on Total Mortality: Results from 29 European Cities within the APHEA2 Project , 2001, Epidemiology.